People with impaired glucose regulation, including those with diabetes, tend to lose less weight on these medications
Trulicity and Ozempic are popular GLP-1 receptor agonists FDA-approved to treat type 2 diabetes and lower the risk of serious cardiovascular problems in certain people with existing heart disease or risk factors for heart disease
Last reviewed: May 25, 2026 Last updated: May 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Semaglutide is the first drug approved by the Food and Drug Administration (FDA) for chronic weight management/weight loss since 2014 and is marketed under brand names such as Ozempic, Wegovy, and a few other names
Most cash-pay compounded GLP-1 telehealth programs operate on the same model
The stock has experienced dramatic price swings over the past year but has gone literally nowhere, up less than 1% as of this writing
